Intelligence · Clinical Development
Pipeline search results
Programs matching “prostate-cancer” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 133 pipeline programs matching "prostate-cancer" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
177Lu-TLX591
Telix Innovations
Metastatic Castration-resistant Prostate Cancer
1 trial -
6-month course of antiandrogen drugs
The First People's Hospital of Lianyungang
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
1 trial -
Abiraterone - Usual
Lxo Ireland Designated Activity Company
Prostate Cancer
1 trial -
Aglatimagene besadenovec + valacyclovir
Candel Therapeutics
Prostate Cancer
1 trial -
Apalutamide
Janssen Cilag International NV
Metastatic Castrate-sensitive Prostate Cancer
1 trial -
CABAZITAXEL
Sanofi Pasteur
Prostate Cancer Metastatic
1 trial -
Cabozantinib
Takeda
Metastatic Prostate Cancer
1 trial -
Custirsen
Teva Pharma GmbH
Prostate Cancer
1 trial -
Dendritic cell immunotherapy
NORTHWEST BIOTHERAPEUTICS INC
Prostate Cancer
1 trial -
Docetaxel
AstraZeneca
Prostate Cancer
1 trial -
Enzalutamide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Metastatic Hormone Sensitive Prostate Cancer
1 trial -
Everolimus
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prostate Cancer
1 trial -
Ga-68-PSMA-11
Telix Innovations
Prostate Cancer
1 trial -
Investigators choice of SoC
Novartis Pharmaceuticals
Prostate Cancer
1 trial -
Leuprorelin
Takeda
Prostate Cancer
1 trial -
Orteronel
Takeda
Prostate Cancer
3 trials -
Relugolix
Myovant Sciences GmbH
Prostate Cancer
1 trial -
SBRT
United Therapeutics Europe Ltd
Prostate Cancer
3 trials -
Standard of Care
Telix Innovations
Metastatic Prostate Cancer
1 trial -
TAP-144-SR(6M)
Takeda
Prostate Cancer
1 trial -
Thalidomide
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
custirsen sodium
Teva Pharma GmbH
Castrate-Resistant Prostate Cancer
1 trial -
educational internet site on prostate cancer screening
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
talazoparib plus enzalutamide
Pfizer
Prostate Cancer
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.